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Shorter sleep duration associated 
with coronary artery calcification
The design of phase IV clinical trials in nephrology has made a 
decided move toward the use of intermediate outcomes. While this is 
an advantage in that generally fewer subjects need to be enrolled and 
followed for shorter periods of time, the inherent caveat lies in the 
validation of the intermediate outcome as a true surrogate of the hard 
clinical outcomes such as mortality or cardiovascular events.1 Many 
argue that the validation of coronary artery calcification (CAC) among 
persons with abnormal kidney function is not complete. A new article 
by King et al. provides insight into the investigation of the potential 
mechanisms of its genesis.
In this observational cohort study, healthy participants from a sin-
gle site in the Coronary Artery Risk Development in Young Adults 
(CARDIA) study were included. CAC was measured by computed 
tomography in 2000–2001 and 2005–2006. Participants had no detect-
able calcification at baseline, and their incidence of new calcification 
was the primary outcome. Sleep metrics (wrist actigraphy-measured 
duration and fragmentation, daytime sleepiness, overall quality, self-
reported duration) along with potential confounders (age, sex, race, 
education, apnea risk, smoking status) and mediators (lipids, blood 
pressure, body mass index, diabetes, inflammatory markers, alcohol 
consumption, depression, hostility, self-reported medical conditions) 
were measured and examined for association with incident calcifi-
cation. Approximately 12% developed calcification over the 5-year 
observation period. Longer sleep duration was significantly associated 
with a decreased risk of new calcification (P = 0.01). This association 
persisted in models adjusted for demographics and for medical history 
including apnea risk, as well as known mediators of calcification such 
as lipid and blood pressure parameters. The authors suggest inflam-
matory and hormonal mediators as causes of both CAC and decreased 
sleep duration, and decreased sleep duration resulting in transient 
decreases in glucose tolerance as a cause of CAC. These findings sug-
gest that a renewed interest in sleep may benefit our patients’ health in 
addition to their quality of life. Additionally, we must continue to be 
objective about our understanding of the pathophysiology of arterial 
calcification as we scrutinize metrics such as the CAC score as sur-
rogate markers. (JAMA 2008; 300: 2859–2866)
Lynda Szczech
1JAMA 1999; 282: 771–778.
Met and the epidermal growth 
factor receptor cooperatively 
regulate final nephron number
Kidney development occurs by the interactions between the ureteric 
bud and the adjacent metanephric mesenchyme. While the ureteric 
bud branches to form the collecting ducts, the more proximal parts 
of the nephron develop via mesenchymal–epithelial transforma-
tion of the metanephric mesenchyme cells in contact with the tips 
of ureteric bud branches. The result of this interplay is that the final 
nephron number is determined by the signals that regulate ureteric 
bud branching. A number of these signals have been identified, but 
there is little doubt that more remain to be discovered. During kid-
ney development, Hgf is expressed by the metanephric mesenchyme, 
whereas its receptor (Met) is present on both ureteric bud and mes-
enchymal cells. In vitro work with neutralizing antibodies against Hgf 
showed inhibition of ureteric bud branching, suggesting an impor-
tant role for Hgf. However, loss of either Hgf or Met expression in the 
mouse led to death by approximately embryonic day 13, and early 
kidney development appeared normal. Because ureteric bud branch-
ing continues through embryonic day 18, the exact role of Hgf–Met 
signaling in the development of the collecting system and nephron 
number remained unclear. Ishibe et al. now use Cre-loxP technology 
to address this question. They found that deletion of the Met recep-
tor selectively in the collecting system (Met fl/fl;HoxB7-Cre) did not 
result in abnormal morphology, but the kidneys of these mice had a 
35% reduction in nephron number at 12 weeks of age and glomerular 
hypertrophy by 1 year of age (Figure). Examination of these collecting 
ducts revealed sustained upregulation and activation of the Egf recep-
tor. Moreover, addition of Egf to embryonic kidneys (with deleted Met 
in the ureteric bud) grown in vitro rescued the decrease in ureteric 
bud branching observed in vivo. Finally, mice lacking both Met and 
Egfr signaling in the collecting duct had a marked decrease in ureteric 
bud branching, small kidneys, renal failure, and early death. Thus, Met 
and the Egf receptor act cooperatively to regulate branching of the 
ureteric bud and nephron number. (Development 2009; 136: 337–345; 
doi:10.1242/10.1242/dev.024463)
Juan Oliver 
Vasopressin signaling pathway  
in primary cilia of renal epithelia
The primary cilium is a solitary, sensory organelle projecting from 
the apical surface of many cells. Most renal tubular epithelial cells of 
Deletion of Met in collecting duct (Metfl/fl;HoxB7-Cre) reduces nephron 
number. (a) Glomeruli at 12 and 52 weeks from Metfl/fl;HoxB7-Cre and 
Met+/+;HoxB7-Cre (control) mice. (b) Quantification of glomerular surface 
area from kidney sections. (c) Representative image of isolated glomeruli 
from Metfl/fl;HoxB7-Cre and control mice. (d) Quantification of total 
glomeruli per mouse in Metfl/fl;HoxB7-Cre and control.
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the mammalian nephron, with the exception of intercalated cells in 
the collecting duct, contain a single primary cilium, which responds 
to fluid flow or mechanical bending by eliciting cytosolic calcium2+ 
signals. The signaling pathways for the regulation of ciliary-located 
channel function are unknown. In a recent publication, Raychowd-
hury et al. report the presence of type 2 vasopressin receptor (V2R) 
in primary cilia of LLC-PK1 cells (renal epithelial cells derived from 
pig kidneys). While hormone receptors in renal tubular epithelial 
cells have been mostly located to the basolateral membrane of the 
cells, several receptors, such as V2R and parathyroid hormone 
receptor, as well as the vasopressin type 1 receptor, have been found 
in the luminal aspect of tubular epithelia. The function of these 
luminal receptors remains unclear. The authors demonstrated the 
presence of V2R in the cilia by the spontaneous fluorescence of a 
V2R-gfp chimera (Figure) and confirmed it by immunocytochemi-
cal analysis in LLC-PK1 cells stained with anti-V2R antibodies and 
in LLC-PK1 cells overexpressing a V2R-Flag chimera, with an anti-
Flag antibody. They also demonstrated that ciliary V2R colocalized 
with adenylyl cyclase in all cell types tested. Finally, they demon-
strated functional coupling of the ciliary receptors with adenylyl 
cyclase by measuring cyclic adenosine monophosphate (cAMP) 
production in isolated cilia and by testing vasopressin-induced 
cation-selective channel activity either in reconstituted lipid bilay-
ers or by membrane-attached patch clamping: the addition of either 
vasopressin (trans) or forskolin (cis) stimulated cation-selective 
channel activity in ciliary membranes. These results provide the 
first demonstration of V2R in primary cilia of renal epithelial cells, 
and a functional cAMP-signaling pathway, which targets ciliary 
channel function and may help control the sensory function of the 
primary cilium. (Am J Physiol Renal Physiol 2009; 296: F87–F97; 
doi:10.1152/ajprenal.90509.2008)
Juan Oliver
STK39 is a hypertension 
susceptibility gene
Essential hypertension (EH) is widely believed to involve multi-
ple genes with variant alleles. As with other complex disorders, 
manifestation of EH in any single individual is likely dependent 
on a variety of genetic and environment factors, making identifi-
cation of EH susceptibility genes in the general population a major 
challenge. In contrast, studies on the genetic basis of rare blood 
pressure monogenetic disorders have identified mutations in 
genes affecting a single physiological pathway: renal salt transport. 
Although such studies highlight the importance of extracellular 
fluid volume to blood pressure regulation, the underlying genetic 
basis for EH remains poorly understood. To identify common EH 
susceptibility genes, Wang et al. conducted a genome-wide asso-
ciation analysis in the Old Order Amish, a closed population with 
descendents from a small number of founders that has a relatively 
homogeneous lifestyle, making it ideal for identifying genes that 
underlie complex diseases. They analyzed genotype data for systo-
lic blood pressure and diastolic blood pressure in 542 subjects. 
This approach identified a novel hypertension susceptibility gene, 
STK39 (a serine/threonine kinase gene), in which common vari-
ants were associated with blood pressure levels. They confirmed 
this association in an independent Amish and four non-Amish 
Caucasian samples, including the Diabetes Genetics Initiative, 
Framingham Heart Study, GenNet, and Hutterites. Functional 
studies in cells showed that STK39 interacted with WNK kinases 
and cation-chloride cotransporters, mutations that are known to 
cause monogenic forms of blood pressure disorders. The authors 
also found that STK39 was expressed in the distal nephron (Fig-
ure), where it may interact with these proteins. Although none 
of the associated single-nucleotide polymorphisms altered pro-
tein structure, they identified and experimentally confirmed a 
highly conserved element with in vitro transcription activity as a 
functional candidate for the association. Thus, variants in STK39 
may influence blood pressure by increasing STK39 expression 
and consequently altering renal Na+ excretion, thus unifying rare 
and common blood pressure-regulating alleles in the same physi-
ological pathway. (Proc Natl Acad Sci USA 2009; 106: 226–231; 
doi:10.1073/pnas.0808358106)
Juan Oliver 
Localization of V2R in primary cilia of renal epithelial cells. V2R was localized 
to the primary cilia of confluent wild-type LLC-PK1 renal epithelial cells 
(WT) and further confirmed in cells expressing either the V2R-Flag or the 
V2R-gfp chimera. Cells were also stained with mouse anti-acetylated tubulin 
antibody (Ac-tubulin; red). DAPI fluorescence (blue) is shown for contrast.
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Immunolocalization of SPAK in kidney. (a) SPAK strongly localizes to the 
thick ascending limb (TAL) of the loop of Henle and the cortical collecting 
duct (CCD). (b) Immunolocalization of aquaporin 2 in the same section 
as in a as a segment-specific marker for CCDs. (c) Immunolocalization of 
SPAK in the distal convoluted tubules (DCT). (d) Immunolocalization of 
sodium chloride cotransporter as a segment-specific marker for DCTs.
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